{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:52Z","timestamp":1740106912903,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2314-B-002-189-MY3"],"award-info":[{"award-number":["MOST 104-2314-B-002-189-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00277-018-3461-z","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T22:58:54Z","timestamp":1532905134000},"page":"1037-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-dose splenic irradiation is an alternative therapy for symptomatic splenomegaly in patients with myelofibrosis"],"prefix":"10.1007","volume":"98","author":[{"given":"Ming-Shan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0054-887X","authenticated-orcid":false,"given":"Sung-Hsin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"issue":"6","key":"3461_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/cam4.136","volume":"2","author":"D Mitra","year":"2013","unstructured":"Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, Sarlis NJ (2013) Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review. Cancer Med 2(6):889\u2013898","journal-title":"Cancer Med"},{"issue":"2","key":"3461_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","volume":"118","author":"R Scherber","year":"2011","unstructured":"Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferarri ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Harrison CN, Radia D, Mesa RA (2011) The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood 118(2):401\u2013408","journal-title":"Blood"},{"issue":"1","key":"3461_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.22365","volume":"109","author":"RA Mesa","year":"2007","unstructured":"Mesa RA, Niblack J, Wadleigh M, Verstovsek S, Camoriano J, Barnes S, Tan AD, Atherton PJ, Sloan JA, Tefferi A (2007) The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients. Cancer 109(1):68\u201376","journal-title":"Cancer"},{"issue":"4","key":"3461_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jso.23846","volume":"111","author":"KL Rialon","year":"2015","unstructured":"Rialon KL, Speicher PJ, Ceppa EP, Rendell VR, Vaslef SN, Beaven A, Tyler DS, Blazer DG 3rd (2015) Outcomes following splenectomy in patients with myeloid neoplasms. J Surg Oncol 111(4):389\u2013395","journal-title":"J Surg Oncol"},{"issue":"6","key":"3461_CR5","first-page":"619","volume":"65","author":"G Barugola","year":"2010","unstructured":"Barugola G, Cavallini A, Lipari G, Armatura G, Mantovani W, Baggio E (2010) The role of splenectomy in myelofibrosis with myeloid metaplasia. Minerva Chir 65(6):619\u2013625","journal-title":"Minerva Chir"},{"issue":"2","key":"3461_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","volume":"103","author":"MA Elliott","year":"1998","unstructured":"Elliott MA, Chen MG, Silverstein MN, Tefferi A (1998) Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol 103(2):505\u2013511","journal-title":"Br J Haematol"},{"issue":"2","key":"3461_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/00000421-200304000-00016","volume":"26","author":"JT McFarland","year":"2003","unstructured":"McFarland JT, Kuzma C, Millard FE, Johnstone PA (2003) Palliative irradiation of the spleen. Am J Clin Oncol 26(2):178\u2013183","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"3461_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1179\/1607845414Y.0000000192","volume":"20","author":"N Ishibashi","year":"2015","unstructured":"Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T, Tanaka Y (2015) Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma. Hematology 20(4):203\u2013207","journal-title":"Hematology"},{"issue":"4","key":"3461_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00066-011-2252-4","volume":"187","author":"J Kriz","year":"2011","unstructured":"Kriz J, Micke O, Bruns F, Haverkamp U, Mucke R, Schafer U, Seegenschmiedt H, Muller RP, Eich HT (2011) Radiotherapy of splenomegaly: a palliative treatment option for a benign phenomenon in malignant diseases. Strahlenther Onkol 187(4):221\u2013224","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"3461_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1054\/blre.1999.0110","volume":"13","author":"MA Elliott","year":"1999","unstructured":"Elliott MA, Tefferi A (1999) Splenic irradiation in myelofibrosis with myeloid metaplasia: a review. Blood Rev 13(3):163\u2013170","journal-title":"Blood Rev"},{"issue":"2","key":"3461_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","volume":"8","author":"T Barbui","year":"2018","unstructured":"Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P, Orazi A, Tefferi A (2018) The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 8(2):15","journal-title":"Blood Cancer J"},{"key":"3461_CR12","unstructured":"Bethesda, MD, US Department of Health and Human Services, National Institutes of Health, National\u00a0Cancer Institute. National Cancer Institute (2009) Common Terminology Criteria for Adverse Events\u00a0(CTCAE), Version 4.0. Available from: \n                    http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html\n                    \n                  . Accessed 28 May 2009"},{"issue":"3","key":"3461_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0167-8140(00)00316-9","volume":"58","author":"M Weinmann","year":"2001","unstructured":"Weinmann M, Becker G, Einsele H, Bamberg M (2001) Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol 58(3):235\u2013246","journal-title":"Radiother Oncol"},{"issue":"1\u20132","key":"3461_CR14","first-page":"23","volume":"25","author":"M Galdiero","year":"1994","unstructured":"Galdiero M, Cipollaro del\u2019Ero G, Folgore A, Cappello M, Giobbe A, Sasso FS (1994) Effects of irradiation doses on alterations in cytokine release by monocytes and lymphocytes. J Med 25(1\u20132):23\u201340","journal-title":"J Med"},{"issue":"6","key":"3461_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","volume":"58","author":"H Wagner Jr","year":"1986","unstructured":"Wagner H Jr, McKeough PG, Desforges J, Madoc-Jones H (1986) Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea. Cancer 58(6):1204\u20131207","journal-title":"Cancer"},{"key":"3461_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1748-717X-9-86","volume":"9","author":"F Bruns","year":"2014","unstructured":"Bruns F, Bremer M, Dettmer A, Janssen S (2014) Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data. Radiat Oncol 9:86","journal-title":"Radiat Oncol"},{"issue":"11","key":"3461_CR17","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1182\/blood.V99.11.4228","volume":"99","author":"M Picardi","year":"2002","unstructured":"Picardi M, Martinelli V, Ciancia R, Soscia E, Morante R, Sodano A, Fortunato G, Rotoli B (2002) Measurement of spleen volume by ultrasound scanning in patients with thrombocytosis: a prospective study. Blood 99(11):4228\u20134230","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3461-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T02:43:35Z","timestamp":1568947415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3461"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3461-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Research Ethical Committee of National Taiwan University Hospital (NTUH: 201410063RINB). The patients\u2019 medical data were anonymized prior to access and analysis. The institutional review board has waived the need for written informed consent from study subjects because all potentially patient-identifying information was removed prior to data analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}